Global /South Korea /Healthcare /Drug Manufacturers - Specialty & Generic /175250
chevron_leftBack
Icure Pharmaceutical InCorp. logo

Icure Pharmaceutical InCorp.

175250
KRX: 175250 Delayed
2,170KRW 12%
1.39 USD
As of 6 June 2026, Icure Pharmaceutical InCorp. has a market cap of $52.9M USD, ranking #30202 globally and #1702 in South Korea. It ranks #2737 in the Healthcare sector, and #157 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
30202
Country Rank
1702
Sector Rank
2737
Industry Rank
157
Key Stats
Market Cap
$52.9MUSD
81.09B KRW
Enterprise Value
$73.95MUSD
115.36B KRW
Revenue (TTM)
$54.4MUSD
83.38B KRW
EBITDA (TTM)
-$7.41MUSD
-11.55B KRW
Net Income (TTM)
-$21.92MUSD
-33.6B KRW
EBITDA Margin
-14%
Profit Margin
-40%
PS Ratio
1.0
PB Ratio
2.9
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Young-Kwon Choi open_in_new
Employees
220
Founded
2000
Website
icure.co.kr open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
12% 20% 13% 5.9% 28% -25%

News

Loading...

Markets

Exchange Ticker Price
Korea Exchange
MIC: XKRX
PRIMARY
175250
아이큐어(주)
ISIN: KR7175250000
Shares Out.:
37.37M1 Shares Float: 31.526M2
TV:
SA:
YF:
GF:
BA:
MS:
2,170 KRW
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Icure Pharmaceutical InCorp.

Icure Pharmaceutical Incorporation, a biopharmaceutical company, researches, develops, and sells pharmaceutical and cosmetic products in South Korea. The company offers functional, nature-derived, derma, and customized cosmetics products. It also offers eye gel, hydro nude gel, lip gel mask, and functional patch products; and sheet, mud, foil, and melting masks. In addition, the company provides body and haircare products, including naturally derived hair and baby line, cleansing tissue, and wet wipes. Further, it offers perfumes, textile perfumes, body mists, and hair and body fragrances. Icure Pharmaceutical Incorporation was founded in 2000 and is based in Seoul, South Korea.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (South Korea)
Name
Market Cap diff.
PE
$539.11M
826.36B KRW
919%
8.4
220100
$278.08M
426.25B KRW
426%
-
200130
$218.56M
335.01B KRW
313%
-
$203.29M
311.61B KRW
284%
16.3
194700
$167.22M
256.31B KRW
216%
7.4
$98.78M
151.41B KRW
87%
17.8
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
PE
$37.66B
108.92B ILS
71K%
24.2
$29.56B
56K%
-
$15.86B
107.34B CNY
30K%
16.0
CIPLA
$11.12B
1.06T INR
21K%
23.4
LUPIN
$11.0B
1.05T INR
21K%
22.7
$9.1B
61.6B CNY
17K%
80.6
chevron_leftBack